JPMORGAN CHASE & CO

Position in ORKA — Oruka Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in ORKA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$62,338,917

+$61,720,079 QoQ

Shares Held

655,027

+3108.2% QoQ

Ownership

0.989%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 254 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 88% Shared 0% None 12%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. ORKA ranks #25 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$62,338,917	655,027	+3108.2%	Shares	Other	2026-08-12
2025-12-31	$618,838	20,417	+41.0%	Shares	Defined	2026-02-11
2025-09-30	$278,430	14,479	-6.1%	Shares	Defined	2025-11-07
2025-06-30	$172,913	15,425	+567.7%	Shares	Defined	2025-08-12
2025-03-31	$23,700	2,310	-17.5%	Shares	Defined	2025-05-12
2024-12-31	$54,292	2,800	—	Shares	Defined	2025-02-12
2024-06-30 ABIO	—	16	-11.1%	Shares	Defined	2024-08-12
2024-03-31 ABIO	—	18	+12.5%	Shares	Defined	2024-05-10
2023-12-31 ABIO	—	16	+33.3%	Shares	Defined	2024-02-12
2023-09-30 ABIO	—	12	-98.2%	Shares	Defined	2023-11-14
2022-03-31 ABIO	—	675	+407.5%	Shares	Defined	2022-05-11
2021-06-30 ABIO	—	133	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.